# The Human Medicines Regulations 2012, Paragraph 11


A reference to the expiry date printed on the packaging of the product with—
(a) a warning against using the product after that date;
(b) if appropriate, details of special storage precautions to be taken;
(c) if necessary, a warning concerning visible signs of deterioration;
(d) the full qualitative composition (in active substances and excipients), and the quantitative composition in active substances, using common names, of each presentation of the medicinal product;
(e) for each presentation of the product, the pharmaceutical form and content in weight, volume or units of dosage;
(f) the name and address of the holder of the UK marketing authorisation ..., Article 126a authorisation or traditional herbal registration relating to the product and, if applicable, the name of the holder's appointed representative; and
(g) the name and address of the manufacturer of the product.

---
Source: https://www.legislation.gov.uk/uksi/2012/1916/schedule/27/paragraph/11 (the official version)
Page: https://openlegislation.uk/human-medicines-regulations-2012/schedule-27/paragraph-11
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

